SCHEMBL17895667

SCHEMBL17895667

CCCC(O)(c1nc2ccc(OC)cc2s1)c1cnccc1OCC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.41
▸ NPC1 O15118 5/20 0.41
▸ MAPT P10636 4/20 0.41
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ TP53 P04637 4/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ POLB P06746 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ CD274 Q9NZQ7 1/20 0.40
▸ TSHR P16473 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ TOP2A P11388 1/20 0.39
▸ LMNA P02545 3/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ SCD O00767 1/20 0.39
▸ WNT3A P56704 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20965304 0.94 MAPT (0.39) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895698 0.90 NPC1 (0.41) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895635 0.88 MAPT (0.39) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895647 0.87 HCRTR1 (0.38) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895609 0.87 SLC6A2 (0.39) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895561 0.87 RAB9A (0.36) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895648 0.87 DYRK1A (0.38) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL29898500 0.87 DYRK1A (0.38) RAB9ANPC1MAPTSMN1; SMN2TP53
SCHEMBL17895567 0.86 CSNK1D (0.37) RAB9ANPC1TP53KDM4EGLA
SCHEMBL17895616 0.85 DYRK1A (0.36) RAB9ANPC1MAPTSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107531631-B Methods and agents for treating diseases 安吉昂生物医药公司 2021-09-03 — — CN claimed
EP-3240778-A1 METHODS AND AGENTS FOR TREATING DISEASE Angion Biomedica Corp. (US) 2017-11-08 — — EP claimed
WO-2016109492-A1 METHODS AND AGENTS FOR TREATING DISEASE ANGION BIOMEDICA CORP (US) 2016-07-07 — — WO claimed
CN-107531631-B Methods and agents for treating diseases 安吉昂生物医药公司 2021-09-03 — — CN disclosed
EP-3240778-A1 METHODS AND AGENTS FOR TREATING DISEASE Angion Biomedica Corp. (US) 2017-11-08 — — EP disclosed
WO-2016109492-A1 METHODS AND AGENTS FOR TREATING DISEASE ANGION BIOMEDICA CORP (US) 2016-07-07 — — WO disclosed
Send feedback